Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including... see more

TSX:CURA - Post Discussion

Curaleaf Holdings Inc > CURA Up in Q4 to $352Mil in 2022 from Q4 2021 $320Mil NICE!!
View:
Post by blackspade799 on Apr 19, 2023 9:36pm

CURA Up in Q4 to $352Mil in 2022 from Q4 2021 $320Mil NICE!!

CURA Up Q4 to $352Mil in 2022 from $320Mil in Q4 in 2021. So we are up $32Mill for Q4 Not too shabby!!

$1.2Billion in 2021 To $1.337Billion in 2022 

I see growth and with reduction in Capex and greater growth in the U.S. and EU CURA is a BUY all day long!!!
Comment by Bullknit101 on Apr 19, 2023 10:13pm
Great top line for sure!
Comment by blackspade799 on Apr 19, 2023 10:28pm
Im surprise i did not think they would of been over $330Mil never mind $352Mil for Q4. CURA grew $137Mil in 2022. Thats massive!! considering how poor the over all market was trending. With EU growing 100% YoY CURA will continue to see much greater growth as Germany UK opens up. May will be very interesting as the CSE lays down the new rules for their Senior tier listings. CURA is with out ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities